Alogliptin benzoate for the treatment of type 2 diabetes.

Alogliptin benzoate for the treatment of type 2 diabetes.

Item
http://www.wikidata.org/entity/Q37980541
Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studiesAlogliptin benzoate for management of type 2 diabetesSitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoformsDipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.Alogliptin (nesina) for adults with type-2 diabetes.Treating the obese diabetic.Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes.DPP-4 inhibitors: focus on safety.Development and Validation of an HPLC Method for Determination of Antidiabetic Drug Alogliptin Benzoate in Bulk and Tablets
P2860

Alogliptin benzoate for the treatment of type 2 diabetes.

Item
http://www.wikidata.org/entity/Q37980541
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alogliptin benzoate for the treatment of type 2 diabetes.
@en
Alogliptin benzoate for the treatment of type 2 diabetes.
@nl
type
label
Alogliptin benzoate for the treatment of type 2 diabetes.
@en
Alogliptin benzoate for the treatment of type 2 diabetes.
@nl
prefLabel
Alogliptin benzoate for the treatment of type 2 diabetes.
@en
Alogliptin benzoate for the treatment of type 2 diabetes.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Alogliptin benzoate for the treatment of type 2 diabetes.
@en
P2093
P2860
P304
P31
P356
10.1517/14656566.2012.656088
P407
P433
P478
P577
P698
P921